@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MSQDMTWZ-7
  skos:prefLabel "Antagonistes muscariniques"@fr, "Muscarinic Antagonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-LD3NXJ47-1
  skos:prefLabel "Anti-Ulcer Agents"@en, "Antiulcéreux"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-S7HZM4BN-8
  skos:prefLabel "Benzodiazepinones"@en, "Benzodiazépinones"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-T6C5KX7G-S .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T6C5KX7G-S
  skos:altLabel "10YM403FLS"@en, "10YM403FLS"@fr, "28797-61-7 (Pirenzepine)"@fr, "28797-61-7 (Pirenzepine)"@en, "Pirenzepin"@en, "6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-"@fr, "Pyrenzepine"@en, "6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-"@en, "3G0285N20N"@fr, "3G0285N20N"@en ;
  mesh:allowableQualifier jvr:-NHL3D2X0-S, jvr:-WK5F724J-1, jvr:-R3QWLHRG-V, jvr:-BT300B3G-Q, jvr:-TJHVZCRZ-0, jvr:-S0CS1X5R-5, jvr:-Q3979798-W, jvr:-R0ZCQ8X6-J, jvr:-G30ZJ446-J, jvr:-M63HSDM7-1, jvr:-HQRFT0C6-B, jvr:-G4R176S9-J, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-XV06LPML-W, jvr:-W6SQV79N-S, jvr:-L6C0XPHT-4, jvr:-T9HQD7ST-J, jvr:-FWD2BGQ0-9, jvr:-NFTHND7Q-8, jvr:-CB30NGKB-3, jvr:-H7K65Q8S-Z, jvr:-NKM836P1-M ;
  mesh:pharmacologicalAction jvr:-MSQDMTWZ-7, jvr:-LD3NXJ47-1 ;
  skos:hiddenLabel "Pirenzepin Von Ct"@en, "LS-519"@fr, "LS-519"@en, "Pirenzepin-Ratiopharm"@en, "Gastrozepin"@en, "Piren-Basan"@en, "Ulgescum"@en, "Gastrotsepin"@en, "Ulcoprotect"@en, "L-S 519"@en, "Pirenzepine Dihydrochloride"@en, "LS519"@fr, "Dichlorhydrate de pirenzépine"@fr ;
  skos:broader jvr:-S7HZM4BN-8 ;
  dc:modified "2017-05-24"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  dc:established "1987-01-01"^^xsd:date ;
  skos:prefLabel "Pirenzepine"@en, "Pirenzépine"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D010890> ;
  skos:definition "An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients."@en ;
  dc:created "1986-04-09"^^xsd:date ;
  skos:inScheme jvr: .

